Wisconsin § 961.385 - Prescription drug monitoring program.

§ 961.385. Prescription drug monitoring program.

961.385(1) (1) In this section: 961.385(1)(a) (a) “Administer” means the direct application of a monitored prescription drug, whether by injection, ingestion, or any other means, to the body of a patient by any of the following: 961.385(1)(a)1. 1. A practitioner or his or her agent. 961.385(1)(a)2. 2. A patient at the direction of a practitioner. 961.385(1)(a)3. 3. A pharmacist. 961.385(1)(ab) (ab) “Agent” means an authorized person who acts on behalf of or at the direction of another person. 961.385(1)(ac) (ac) “Board” means the controlled substances board. 961.385(1)(ad) (ad) “Business day” means any day on which the offices of the department of safety and professional services are open. 961.385(1)(ae) (ae) “Deliver” or “delivery” means the actual, constructive, or attempted transfer of a monitored prescription drug from one person to another. 961.385(1)(af) (af) “Dispense” means to deliver a monitored prescription drug pursuant to the lawful prescription order of a practitioner, including the compounding, packaging, or labeling necessary to prepare the monitored prescription drug for delivery. 961.385(1)(ag) (ag) “Monitored prescription drug” means a substance identified in s.